Cargando…
Addressing Bias in Responder Analysis of Patient-Reported Outcomes
INTRODUCTION: Quantitative patient-reported outcome (PRO) measures ideally are analyzed on their original scales and responder analyses are used to aid the interpretation of those primary analyses. As stated in the FDA PRO Guidance for Medical Product Development (2009), one way to lend meaning and...
Autores principales: | Cappelleri, Joseph C., Chambers, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8332587/ https://www.ncbi.nlm.nih.gov/pubmed/34046875 http://dx.doi.org/10.1007/s43441-021-00298-5 |
Ejemplares similares
-
Key considerations to reduce or address respondent burden in patient-reported outcome (PRO) data collection
por: Aiyegbusi, Olalekan Lee, et al.
Publicado: (2022) -
Errors in reported degrees and respondent driven sampling: Implications for bias()
por: Mills, Harriet L., et al.
Publicado: (2014) -
Considerations on the Use of Patient-Reported Outcomes in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011) -
Addressing racial bias in wards
por: Tsai, Jennifer, et al.
Publicado: (2018) -
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
por: Panés, Julián, et al.
Publicado: (2015)